{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:29:57Z","timestamp":1791044997364,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In vitro studies have demonstrated that deletions and point mutations introduced into each 21 bp imperfect repeat of <jats:italic>Tax<\/jats:italic>-responsive element (TRE) of the genuine human T-cell leukemia virus type I (HTLV-1) viral promoter abolishes <jats:italic>Tax<\/jats:italic> induction. Given these data, we hypothesized that similar mutations may affect the proliferation of HTLV-1i<\/jats:p>\n            <jats:p>nfected cells and alter the proviral load (PvL). To test this hypothesis, we conducted a cross-sectional genetic analysis to compare the near-complete LTR nucleotide sequences that cover the TRE1 region in a sample of HTLV-1 asymptomatic carriers with different PvL burden.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of 94 asymptomatic HTLV-1 carriers with both sequence from the 5' long terminal repeat (LTR) and a PvL for <jats:italic>Tax<\/jats:italic> DNA measured using a sensitive SYBR Green real-time PCR were studied. The 94 subjects were divided into three groups based on PvL measurement: 31 low, 29 intermediate, and 34 high. In addition, each group was compared based on sex, age, and viral genotypes. In another analysis, the median PvLs between individuals infected with mutant and wild-type viruses were compared.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Using a categorical analysis, a G232A substitution, located in domain A of the TRE-1 motif, was detected in 38.7% (12\/31), 27.5% (8\/29), and 61.8% (21\/34) of subjects with low, intermediate, or high PvLs, respectively. A significant difference in the detection of this mutation was found between subjects with a high or low PvL and between those with a high or intermediate PvL (both <jats:italic>p<\/jats:italic> &lt; 0.05), but not between subjects with a low or intermediate PvL (<jats:italic>p<\/jats:italic> &gt; 0.05). This result was confirmed by a non-parametric analysis that showed strong evidence for higher PvLs among HTLV-1 positive individuals with the G232A mutation than those without this mutation (<jats:italic>p<\/jats:italic> &lt; 0.03). No significant difference was found between the groups in relation to age, sex or viral subtypes (<jats:italic>p<\/jats:italic> &gt; 0. 05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The data described here show that changes in domain A of the HTLV-1 TRE-1 motif resulting in the G232A mutation may increase HTLV-1 replication in a majority of infected subjects.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1743-422x-8-535","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T19:22:19Z","timestamp":1323804139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Correlation between LTR point mutations and proviral load levels among Human T cell Lymphotropic Virus type 1 (HTLV-1) asymptomatic carriers"],"prefix":"10.1186","volume":"8","author":[{"given":"Walter K","family":"Neto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio C","family":"Da-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AnaCarolina S","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa P","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youko","family":"Nukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester C","family":"Sabino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabri S","family":"Sanabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,13]]},"reference":[{"issue":"12","key":"1683_CR1","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980,77(12):7415-7419. 10.1073\/pnas.77.12.7415","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1683_CR2","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","volume":"79","author":"M Yoshida","year":"1982","unstructured":"Yoshida M, Miyoshi I, Hinuma Y: Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982,79(6):2031-2035. 10.1073\/pnas.79.6.2031","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8488","key":"1683_CR3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","volume":"1","author":"M Osame","year":"1986","unstructured":"Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M: HTLV-I associated myelopathy, a new clinical entity. Lancet 1986,1(8488):1031-1032.","journal-title":"Lancet"},{"issue":"8452","key":"1683_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985,2(8452):407-410.","journal-title":"Lancet"},{"issue":"8801","key":"1683_CR5","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/0140-6736(92)90699-4","volume":"339","author":"M Mochizuki","year":"1992","unstructured":"Mochizuki M, Yamaguchi K, Takatsuki K, Watanabe T, Mori S, Tajima K: HTLV-I and uveitis. Lancet 1992,339(8801):1110.","journal-title":"Lancet"},{"issue":"8569","key":"1683_CR6","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/S0140-6736(87)91362-6","volume":"2","author":"M Sugimoto","year":"1987","unstructured":"Sugimoto M, Nakashima H, Watanabe S, Uyama E, Tanaka F, Ando M, Araki S, Kawasaki S: T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet 1987,2(8569):1220.","journal-title":"Lancet"},{"issue":"10","key":"1683_CR7","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2169\/internalmedicine.31.1213","volume":"31","author":"H Kawai","year":"1992","unstructured":"Kawai H, Saito M, Takagi M, Tsuchihashi T, Arii Y, Kondo A, Iwasa M, Hirose T, Hizawa K, Saito S: Hashimoto's thyroiditis in HTLV-I carriers. Intern Med 1992,31(10):1213-1216. 10.2169\/internalmedicine.31.1213","journal-title":"Intern Med"},{"issue":"8578","key":"1683_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0140-6736(88)92744-4","volume":"1","author":"JC Vernant","year":"1988","unstructured":"Vernant JC, Buisson G, Magdeleine J, De Thore J, Jouannelle A, Neisson-Vernant C, Monplaisir N: T-lymphocyte alveolitis, tropical spastic paresis, and Sjogren syndrome. Lancet 1988,1(8578):177.","journal-title":"Lancet"},{"issue":"8635","key":"1683_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0140-6736(89)90038-X","volume":"1","author":"K Nishioka","year":"1989","unstructured":"Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M: Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989,1(8635):441.","journal-title":"Lancet"},{"issue":"1","key":"1683_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0736-4679(99)00173-0","volume":"18","author":"RF Edlich","year":"2000","unstructured":"Edlich RF, Arnette JA, Williams FM: Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med 2000,18(1):109-119. 10.1016\/S0736-4679(99)00173-0","journal-title":"J Emerg Med"},{"issue":"33","key":"1683_CR11","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1038\/sj.onc.1206551","volume":"22","author":"M Matsuoka","year":"2003","unstructured":"Matsuoka M: Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene 2003,22(33):5131-5140. 10.1038\/sj.onc.1206551","journal-title":"Oncogene"},{"issue":"4","key":"1683_CR12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","volume":"7","author":"K Verdonck","year":"2007","unstructured":"Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E: Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 2007,7(4):266-281. 10.1016\/S1473-3099(07)70081-6","journal-title":"Lancet Infect Dis"},{"issue":"39","key":"1683_CR13","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","volume":"24","author":"FA Proietti","year":"2005","unstructured":"Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL: Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005,24(39):6058-6068. 10.1038\/sj.onc.1208968","journal-title":"Oncogene"},{"issue":"10","key":"1683_CR14","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1089\/aid.1994.10.1313","volume":"10","author":"M Gasmi","year":"1994","unstructured":"Gasmi M, Farouqi B, d'Incan M, Desgranges C: Long terminal repeat sequence analysis of HTLV type I molecular variants identified in four north African patients. AIDS Res Hum Retroviruses 1994,10(10):1313-1315. 10.1089\/aid.1994.10.1313","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"Pt 12","key":"1683_CR15","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1099\/0022-1317-75-12-3655","volume":"75","author":"AU Vidal","year":"1994","unstructured":"Vidal AU, Gessain A, Yoshida M, Tekaia F, Garin B, Guillemain B, Schulz T, Farid R, De The G: Phylogenetic classification of human T cell leukaemia\/lymphoma virus type I genotypes in five major molecular and geographical subtypes. J Gen Virol 1994,75(Pt 12):3655-3666.","journal-title":"J Gen Virol"},{"issue":"Pt 11","key":"1683_CR16","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1099\/0022-1317-79-11-2695","volume":"79","author":"S Van Dooren","year":"1998","unstructured":"Van Dooren S, Gotuzzo E, Salemi M, Watts D, Audenaert E, Duwe S, Ellerbrok H, Grassmann R, Hagelberg E, Desmyter J, et al.: Evidence for a post-Columbian introduction of human T-cell lymphotropic virus [type I] [corrected] in Latin America. J Gen Virol 1998,79(Pt 11):2695-2708.","journal-title":"J Gen Virol"},{"issue":"4","key":"1683_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/ijc.2910470403","volume":"47","author":"T Kinoshita","year":"1991","unstructured":"Kinoshita T, Tsujimoto A, Shimotohno K: Sequence variations in LTR and env regions of HTLV-I do not discriminate between the virus from patients with HTLV-I-associated myelopathy and adult T-cell leukemia. Int J Cancer 1991,47(4):491-495. 10.1002\/ijc.2910470403","journal-title":"Int J Cancer"},{"issue":"7","key":"1683_CR18","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1128\/jvi.65.7.3770-3778.1991","volume":"65","author":"F Komurian","year":"1991","unstructured":"Komurian F, Pelloquin F, de The G: In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies. J Virol 1991,65(7):3770-3778.","journal-title":"J Virol"},{"issue":"12","key":"1683_CR19","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1073\/pnas.80.12.3618","volume":"80","author":"M Seiki","year":"1983","unstructured":"Seiki M, Hattori S, Hirayama Y, Yoshida M: Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci USA 1983,80(12):3618-3622. 10.1073\/pnas.80.12.3618","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"1683_CR20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/sj.cdd.4401576","volume":"12","author":"DM D'Agostino","year":"2005","unstructured":"D'Agostino DM, Silic-Benussi M, Hiraragi H, Lairmore MD, Ciminale V: The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth. Cell Death Differ 2005,12(Suppl 1):905-915.","journal-title":"Cell Death Differ"},{"key":"1683_CR21","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.2741\/1417","volume":"9","author":"M Bindhu","year":"2004","unstructured":"Bindhu M, Nair A, Lairmore MD: Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression. Front Biosci 2004, 9: 2556-2576. 10.2741\/1417","journal-title":"Front Biosci"},{"issue":"1","key":"1683_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/sj.leu.2402777","volume":"17","author":"F Mortreux","year":"2003","unstructured":"Mortreux F, Gabet AS, Wattel E: Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia 2003,17(1):26-38. 10.1038\/sj.leu.2402777","journal-title":"Leukemia"},{"issue":"39","key":"1683_CR23","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1038\/sj.onc.1208978","volume":"24","author":"R Grassmann","year":"2005","unstructured":"Grassmann R, Aboud M, Jeang KT: Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 2005,24(39):5976-5985. 10.1038\/sj.onc.1208978","journal-title":"Oncogene"},{"issue":"39","key":"1683_CR24","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.1038\/sj.onc.1208975","volume":"24","author":"WW Hall","year":"2005","unstructured":"Hall WW, Fujii M: Deregulation of cell-signaling pathways in HTLV-1 infection. Oncogene 2005,24(39):5965-5975. 10.1038\/sj.onc.1208975","journal-title":"Oncogene"},{"issue":"39","key":"1683_CR25","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.1038\/sj.onc.1208973","volume":"24","author":"F Kashanchi","year":"2005","unstructured":"Kashanchi F, Brady JN: Transcriptional and post-transcriptional gene regulation of HTLV-1. Oncogene 2005,24(39):5938-5951. 10.1038\/sj.onc.1208973","journal-title":"Oncogene"},{"issue":"51","key":"1683_CR26","doi-asserted-by":"publisher","first-page":"49459","DOI":"10.1074\/jbc.M209566200","volume":"277","author":"I Lemasson","year":"2002","unstructured":"Lemasson I, Polakowski NJ, Laybourn PJ, Nyborg JK: Transcription factor binding and histone modifications on the integrated proviral promoter in human T-cell leukemia virus-I-infected T-cells. J Biol Chem 2002,277(51):49459-49465. 10.1074\/jbc.M209566200","journal-title":"J Biol Chem"},{"issue":"8","key":"1683_CR27","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1128\/jvi.65.8.4525-4528.1991","volume":"65","author":"J Fujisawa","year":"1991","unstructured":"Fujisawa J, Toita M, Yoshimura T, Yoshida M: The indirect association of human T-cell leukemia virus tax protein with DNA results in transcriptional activation. J Virol 1991,65(8):4525-4528.","journal-title":"J Virol"},{"issue":"10","key":"1683_CR28","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1128\/MCB.9.10.4152","volume":"9","author":"SJ Marriott","year":"1989","unstructured":"Marriott SJ, Boros I, Duvall JF, Brady JN: Indirect binding of human T-cell leukemia virus type I tax1 to a responsive element in the viral long terminal repeat. Mol Cell Biol 1989,9(10):4152-4160.","journal-title":"Mol Cell Biol"},{"issue":"4714","key":"1683_CR29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.2992082","volume":"229","author":"BK Felber","year":"1985","unstructured":"Felber BK, Paskalis H, Kleinman-Ewing C, Wong-Staal F, Pavlakis GN: The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 1985,229(4714):675-679. 10.1126\/science.2992082","journal-title":"Science"},{"issue":"8","key":"1683_CR30","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1128\/jvi.63.8.3234-3239.1989","volume":"63","author":"J Fujisawa","year":"1989","unstructured":"Fujisawa J, Toita M, Yoshida M: A unique enhancer element for the trans activator (p40tax) of human T-cell leukemia virus type I that is distinct from cyclic AMP- and 12-O-tetradecanoylphorbol-13-acetate-responsive elements. J Virol 1989,63(8):3234-3239.","journal-title":"J Virol"},{"issue":"3","key":"1683_CR31","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/j.1460-2075.1990.tb08194.x","volume":"9","author":"J Montagne","year":"1990","unstructured":"Montagne J, Beraud C, Crenon I, Lombard-Platet G, Gazzolo L, Sergeant A, Jalinot P: Tax1 induction of the HTLV-I 21 bp enhancer requires cooperation between two cellular DNA-binding proteins. EMBO J 1990,9(3):957-964.","journal-title":"EMBO J"},{"issue":"14","key":"1683_CR32","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1073\/pnas.84.14.4919","volume":"84","author":"CA Rosen","year":"1987","unstructured":"Rosen CA, Park R, Sodroski JG, Haseltine WA: Multiple sequence elements are required for regulation of human T-cell leukemia virus gene expression. Proc Natl Acad Sci USA 1987,84(14):4919-4923. 10.1073\/pnas.84.14.4919","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1683_CR33","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1128\/jcm.30.6.1605-1607.1992","volume":"30","author":"W Heneine","year":"1992","unstructured":"Heneine W, Khabbaz RF, Lal RB, Kaplan JE: Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I\/II-seropositive individuals. J Clin Microbiol 1992,30(6):1605-1607.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"1683_CR34","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1128\/jcm.34.10.2635-2638.1996","volume":"34","author":"CC Marchioli","year":"1996","unstructured":"Marchioli CC, Love JL, Abbott LZ, Huang YQ, Remick SC, Surtento-Reodica N, Hutchison RE, Mildvan D, Friedman-Kien AE, Poiesz BJ: Prevalence of human herpesvirus 8 DNA sequences in several patient populations. J Clin Microbiol 1996,34(10):2635-2638.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"1683_CR35","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","volume":"116","author":"M Iwanaga","year":"2010","unstructured":"Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Koh KR, Ogata M, Kikuchi H, Sagara Y, Uozumi K, et al.: Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood 2010,116(8):1211-1219. 10.1182\/blood-2009-12-257410","journal-title":"Blood"},{"issue":"9","key":"1683_CR36","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1089\/aid.1994.10.1135","volume":"10","author":"HF Liu","year":"1994","unstructured":"Liu HF, Vandamme AM, Kazadi K, Carton H, Desmyter J, Goubau P: Familial transmission and minimal sequence variability of human T-lymphotropic virus type I (HTLV-I) in Zaire. AIDS Res Hum Retroviruses 1994,10(9):1135-1142. 10.1089\/aid.1994.10.1135","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"41","key":"1683_CR37","first-page":"04","volume":"41","author":"TA Hall","year":"1999","unstructured":"Hall TA: BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT. Nucleic Acids Symposium Series 1999,41(41):04.","journal-title":"Nucleic Acids Symposium Series"},{"issue":"26","key":"1683_CR38","doi-asserted-by":"crossref","first-page":"15236","DOI":"10.1016\/S0021-9258(19)84815-9","volume":"264","author":"CZ Giam","year":"1989","unstructured":"Giam CZ, Xu YL: HTLV-I tax gene product activates transcription via pre-existing cellular factors and cAMP responsive element. J Biol Chem 1989,264(26):15236-15241.","journal-title":"J Biol Chem"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-535.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:22:20Z","timestamp":1630520540000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-8-535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1683"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-8-535","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"29 September 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"535"}}